MITF — 1298 ClinVar variants

All ClinVar germline MITF variants across every classification, each assembled from ClinVar, gnomAD, AlphaMissense, conservation and more. 592 flagged for review →

77 Pathogenic · 9 Pathogenic/Likely pathogenic · 49 Likely pathogenic · 61 Conflicting · 42 Benign · 16 Benign/Likely benign · 331 Likely benign · 713 Uncertain significance

Full MITF gene report on Sugi Atlas → Gene function, pathways, protein structure, constraint & interactions

⚑ Evidence disagreements 592

Variants where the independent computational evidence doesn't line up with the clinical picture — a QC signal for a second look, not a reclassification.

Predictors vs ClinVar 1

ClinVar calls these pathogenic, but the computational predictors lean tolerated — the highest-value review flag.

Predictors agree, ClinVar conflicts 26

ClinVar submitters conflict, but the independent predictors unanimously agree — a QC review flag, not a reclassification.

Predicted LoF vs a conflicting call 2

ClinVar submitters conflict, and it's a predicted loss-of-function change in a gene where LoF causes disease — flagged for review, not resolved (verify NMD-escape for C-terminal truncations). Non-missense.

Predictors lean, ClinVar uncertain 459

ClinVar classifies these uncertain (VUS), but the independent predictors unanimously lean one way — a triage signal for review, not a reclassification. · showing the 150 best-reviewed of 459

Predictors split 104

The independent predictors disagree with each other — read with care.

All MITF variants

Pathogenic 77

  • c.1031+1G>A Multiple submitters Tietz syndrome
  • c.1179+1G>A Multiple submitters Waardenburg syndrome type 2A
  • c.956-1G>A Multiple submitters Waardenburg syndrome type 2A
  • p.Arg321Ter Multiple submitters MITF-related disorder
  • p.Arg324del Multiple submitters Monogenic hearing loss
  • p.Arg324Ter Multiple submitters Waardenburg syndrome type 2A
  • p.Arg366Ter Multiple submitters Waardenburg syndrome type 2A
  • p.Asp225fs Multiple submitters Waardenburg syndrome type 2A
  • p.Pro272fs Multiple submitters Waardenburg syndrome type 2A
  • p.Ser235Ter Multiple submitters Rare genetic deafness
  • p.Thr299fs Multiple submitters Waardenburg syndrome type 2A
  • c.1032-2A>G Single submitter Monogenic hearing loss
  • c.1179+2T>C Single submitter Tietz syndrome
  • c.1180-5_1203dup Single submitter Waardenburg syndrome type 2A
  • c.33+1G>A Single submitter MITF-related disorder
  • c.763-1G>A Single submitter Waardenburg syndrome type 2A
  • c.880+1del Single submitter Waardenburg syndrome type 2A
  • c.(?_938 Single submitter Rare genetic deafness
  • c.956-2A>G Single submitter Tietz syndrome
  • p.Ala305fs Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Arg323fs Single submitter Waardenburg syndrome type 2A
  • p.Arg324Lys Single submitter Waardenburg syndrome type 2A
  • p.Arg400Ter Single submitter Tietz syndrome
  • p.Asn430fs Single submitter Waardenburg syndrome type 2A
  • p.Asn459fs Single submitter Waardenburg syndrome type 2A
  • p.Asn8fs Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Asp224fs Single submitter Waardenburg syndrome type 2A
  • p.Asp449fs Single submitter
  • p.Asp452fs Single submitter Tietz syndrome
  • p.Cys431fs Single submitter Waardenburg syndrome type 2A
  • p.Gln133Ter Single submitter
  • p.Gln138Ter Single submitter Tietz syndrome
  • p.Gln365fs Single submitter Waardenburg syndrome type 2A
  • p.Gln365Ter Single submitter
  • p.Gln369Ter Single submitter Waardenburg syndrome type 2A
  • p.Gln378Ter Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Gln393fs Single submitter Tietz syndrome
  • p.Glu320Gly Single submitter Waardenburg syndrome type 2A
  • p.Glu333fs Single submitter Waardenburg syndrome type 2A
  • p.Glu425Ter Single submitter Waardenburg syndrome type 2A
  • p.His215fs Single submitter Waardenburg syndrome type 2A
  • p.His316Arg Single submitter
  • p.His316Asp Single submitter Waardenburg syndrome type 2A
  • p.His316fs Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Ile230fs Single submitter Waardenburg syndrome type 2A
  • p.Ile327fs Single submitter Waardenburg syndrome type 2A
  • p.Ile407fs Single submitter Waardenburg syndrome type 2A
  • p.Leu123fs Single submitter Tietz syndrome
  • p.Leu242fs Single submitter Waardenburg syndrome type 2A
  • p.Leu255Ter Single submitter Waardenburg syndrome type 2A
  • p.Leu270= Single submitter Waardenburg syndrome type 2A
  • p.Leu306fs Single submitter
  • p.Leu334fs Single submitter Waardenburg syndrome type 2A
  • p.Leu354Ter Single submitter Tietz syndrome
  • p.Lys312Ter Single submitter Waardenburg syndrome type 2A
  • p.Lys372fs Single submitter Tietz syndrome
  • p.Pro164fs Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Ser216fs Single submitter Waardenburg syndrome type 2A
  • p.Ser219fs Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Ser258fs Single submitter Waardenburg syndrome type 2A
  • p.Ser341Ter Single submitter Waardenburg syndrome type 2A
  • p.Thr254fs Single submitter Waardenburg syndrome type 2A
  • p.Thr293_Ala294insTer Single submitter Waardenburg syndrome type 2A
  • p.Thr293fs Single submitter Waardenburg syndrome type 2A
  • p.Thr443fs Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Thr525fs Single submitter Waardenburg syndrome type 2A
  • p.Trp348Ter Single submitter Rare genetic deafness
  • p.Tyr142Ter Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Tyr237fs Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Tyr265Ter Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.763-2A>C No assertion criteria Waardenburg syndrome type 2A
  • c.955+1G>C No assertion criteria Waardenburg syndrome type 2A
  • p.Arg324Gly No assertion criteria coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness
  • p.Glu382fs No assertion criteria Waardenburg syndrome type 2A
  • p.Gly403fs No assertion criteria Waardenburg syndrome type 2A
  • p.Lys313Asn No assertion criteria coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness
  • p.Ser357Pro No assertion criteria Waardenburg syndrome type 2A

Pathogenic/Likely pathogenic 9

  • c.355-1062G>C Multiple submitters melanoma, cutaneous malignant, susceptibility to, 8
  • p.Arg217Ter Multiple submitters melanoma, cutaneous malignant, susceptibility to, 8
  • p.Arg362Ter Multiple submitters Waardenburg syndrome type 2A
  • p.Arg377Ter Multiple submitters Waardenburg syndrome type 2A
  • p.Gln311Ter Multiple submitters Waardenburg syndrome type 2
  • p.Glu333Ter Multiple submitters Waardenburg syndrome type 2
  • p.Leu147Ter Multiple submitters Tietz syndrome
  • p.Leu318Pro Multiple submitters Tietz syndrome
  • p.Thr410= Multiple submitters melanoma, cutaneous malignant, susceptibility to, 8

Likely pathogenic 49

  • c.1180-2A>G Multiple submitters Waardenburg syndrome
  • c.880+1G>A Multiple submitters Waardenburg syndrome type 2A
  • c.955+1G>A Multiple submitters Waardenburg syndrome type 2A
  • p.Arg310Gly Multiple submitters Waardenburg syndrome type 2A
  • p.Glu309Lys Multiple submitters Tietz syndrome
  • p.Gly351Glu Multiple submitters MITF-related disorder
  • c.1031+1G>C Single submitter Waardenburg syndrome type 2A
  • c.1031+1G>T Single submitter MITF-related disorder
  • c.1031+4A>C Single submitter Waardenburg syndrome type 2A
  • c.1032-1G>C Single submitter
  • c.660_666+6del Single submitter Waardenburg syndrome type 2A
  • c.666+1G>A Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.762+1G>A Single submitter Tietz syndrome
  • c.880+2T>C Single submitter Waardenburg syndrome type 2A
  • c.881-2A>G Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.953_955+3del Single submitter Waardenburg syndrome type 2A
  • c.955+1G>T Single submitter Waardenburg syndrome type 2A
  • p.Ala294fs Single submitter Waardenburg syndrome type 2A
  • p.Ala399fs Single submitter Waardenburg syndrome type 2A
  • p.Arg217fs Single submitter Waardenburg syndrome type 2A
  • p.Arg321Gly Single submitter Waardenburg syndrome type 2A
  • p.Arg321Leu Single submitter Waardenburg syndrome type 2A
  • p.Arg324Thr Single submitter hereditary neoplastic syndrome
  • p.Asn317Lys Single submitter MITF-related disorder
  • p.Asn328Lys Single submitter autosomal dominant nonsyndromic hearing loss
  • p.Asp263fs Single submitter MITF-related disorder
  • p.Gln132fs Single submitter Waardenburg syndrome type 2A
  • p.Gln268Ter Single submitter Waardenburg syndrome type 2A
  • p.Gln393Ter Single submitter MITF-related disorder
  • p.Glu194fs Single submitter Tietz syndrome
  • p.Glu300fs Single submitter Waardenburg syndrome type 2A
  • p.Glu429fs Single submitter Waardenburg syndrome type 2A
  • p.Gly266Ter Single submitter MITF-related disorder
  • p.Gly351Arg Single submitter Waardenburg syndrome type 2A
  • p.His316del Single submitter MITF-related disorder
  • p.Ile319Met Single submitter Tietz syndrome
  • p.Ile319Ser Single submitter
  • p.Ile327Thr Single submitter hearing loss disorder
  • p.Leu244Pro Single submitter Waardenburg syndrome type 2A
  • p.Leu334Arg Single submitter Waardenburg syndrome type 2A
  • p.Leu381fs Single submitter Monogenic hearing loss
  • p.Ser357Tyr Single submitter Waardenburg syndrome type 2A
  • p.Ser432delinsArgThrArgSerTer Single submitter Waardenburg syndrome type 2A
  • p.Tyr10Ter Single submitter Waardenburg syndrome type 2A
  • p.Tyr129Ter Single submitter Waardenburg syndrome type 2A
  • p.Tyr360Ser Single submitter Waardenburg syndrome type 2A
  • p.Asn279fs No assertion criteria MITF-related disorder
  • p.Lys379Ter No assertion criteria coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness
  • p.Tyr265Cys No assertion criteria Waardenburg syndrome ⚠

Conflicting classifications of pathogenicity 61

Benign 42

Benign/Likely benign 16

  • c.1031+31T>C Multiple submitters
  • c.104+23992G>T Multiple submitters
  • c.1180-11T>C Multiple submitters Waardenburg syndrome type 2A
  • c.355-1113C>T Multiple submitters Tietz syndrome
  • c.666+12C>T Multiple submitters melanoma, cutaneous malignant, susceptibility to, 8
  • c.880+9C>G Multiple submitters Waardenburg syndrome type 2
  • c.*12T>C Multiple submitters Waardenburg syndrome type 2A
  • p.Glu394= Multiple submitters Tietz syndrome
  • p.Glu523= Multiple submitters Waardenburg syndrome type 2A
  • p.His122= Multiple submitters Tietz syndrome
  • p.Leu461Ile Multiple submitters coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness
  • p.Leu481= Multiple submitters Tietz syndrome
  • p.Thr522= Multiple submitters Waardenburg syndrome type 2A
  • p.Thr525Ala Multiple submitters Tietz syndrome
  • p.Val427Ala Multiple submitters melanoma, cutaneous malignant, susceptibility to, 8
  • c.*1941A>G Single submitter Tietz syndrome

Likely benign 331

Showing the top 300 by review status; the full set is in the sitemap.

  • c.1032-19T>C Multiple submitters Tietz syndrome
  • c.1032-5C>T Multiple submitters Tietz syndrome
  • c.104+24216T>C Multiple submitters hereditary neoplastic syndrome
  • c.1179+94C>T Multiple submitters
  • c.1180-6T>C Multiple submitters Tietz syndrome
  • c.355-829A>G Multiple submitters
  • c.582+280C>T Multiple submitters
  • c.582+491G>A Multiple submitters
  • c.666+15G>C Multiple submitters Waardenburg syndrome type 2A
  • c.666+8A>G Multiple submitters Tietz syndrome
  • c.667-3C>T Multiple submitters Waardenburg syndrome type 2A
  • c.667-7C>T Multiple submitters Waardenburg syndrome type 2A
  • c.956-4G>A Multiple submitters melanoma, cutaneous malignant, susceptibility to, 8
  • c.956-7C>A Multiple submitters Tietz syndrome
  • p.Ala218= Multiple submitters hereditary neoplastic syndrome
  • p.Ala294= Multiple submitters Tietz syndrome
  • p.Ala356= Multiple submitters hereditary neoplastic syndrome
  • p.Ala371= Multiple submitters hereditary neoplastic syndrome
  • p.Ala38= Multiple submitters
  • p.Ala467= Multiple submitters hereditary neoplastic syndrome
  • p.Ala82= Multiple submitters
  • p.Arg217= Multiple submitters Tietz syndrome
  • p.Arg310= Multiple submitters hereditary neoplastic syndrome
  • p.Arg370= Multiple submitters Tietz syndrome
  • p.Arg377= Multiple submitters hereditary neoplastic syndrome
  • p.Arg386= Multiple submitters Tietz syndrome
  • p.Arg420= Multiple submitters hereditary neoplastic syndrome
  • p.Arg513= Multiple submitters hereditary neoplastic syndrome
  • p.Arg514= Multiple submitters Tietz syndrome
  • p.Asn188= Multiple submitters Tietz syndrome
  • p.Asn267= Multiple submitters hereditary neoplastic syndrome
  • p.Asn460= Multiple submitters Tietz syndrome
  • p.Asn468= Multiple submitters Tietz syndrome
  • p.Asp246= Multiple submitters Tietz syndrome
  • p.Asp416= Multiple submitters hereditary neoplastic syndrome
  • p.Asp452= Multiple submitters hereditary neoplastic syndrome
  • p.Asp483= Multiple submitters hereditary neoplastic syndrome
  • p.Asp487= Multiple submitters Tietz syndrome
  • p.Asp488= Multiple submitters Tietz syndrome
  • p.Cys209= Multiple submitters Tietz syndrome
  • p.Gln135= Multiple submitters hereditary neoplastic syndrome
  • p.Gln138= Multiple submitters hereditary neoplastic syndrome
  • p.Gln141= Multiple submitters Tietz syndrome
  • p.Gln365= Multiple submitters Tietz syndrome
  • p.Gln368= Multiple submitters Tietz syndrome
  • p.Gln424= Multiple submitters hereditary neoplastic syndrome
  • p.Glu192= Multiple submitters hereditary neoplastic syndrome
  • p.Glu208= Multiple submitters Tietz syndrome
  • p.Glu208Gly Multiple submitters Waardenburg syndrome type 2A
  • p.Glu300= Multiple submitters Waardenburg syndrome type 2A
  • p.Glu333= Multiple submitters Tietz syndrome
  • p.Glu382= Multiple submitters Tietz syndrome
  • p.Gly165= Multiple submitters Tietz syndrome
  • p.Gly464= Multiple submitters hereditary neoplastic syndrome
  • p.His215= Multiple submitters hereditary neoplastic syndrome
  • p.His383= Multiple submitters Waardenburg syndrome type 2A
  • p.His402= Multiple submitters hereditary neoplastic syndrome
  • p.His439= Multiple submitters Tietz syndrome
  • p.Ile227= Multiple submitters hereditary neoplastic syndrome
  • p.Ile230= Multiple submitters hereditary neoplastic syndrome
  • p.Ile241= Multiple submitters hereditary neoplastic syndrome
  • p.Ile338= Multiple submitters hereditary neoplastic syndrome
  • p.Leu123= Multiple submitters hereditary neoplastic syndrome
  • p.Leu156= Multiple submitters hereditary neoplastic syndrome
  • p.Leu233= Multiple submitters Tietz syndrome
  • p.Leu337= Multiple submitters Tietz syndrome
  • p.Leu364= Multiple submitters hereditary neoplastic syndrome
  • p.Leu448= Multiple submitters hereditary neoplastic syndrome
  • p.Leu461= Multiple submitters melanoma, cutaneous malignant, susceptibility to, 8
  • p.Lys150= Multiple submitters Tietz syndrome
  • p.Lys350= Multiple submitters Tietz syndrome
  • p.Lys379= Multiple submitters melanoma, cutaneous malignant, susceptibility to, 8
  • p.Pro171= Multiple submitters hereditary neoplastic syndrome
  • p.Pro173= Multiple submitters Tietz syndrome
  • p.Pro256= Multiple submitters Tietz syndrome
  • p.Pro273= Multiple submitters hereditary neoplastic syndrome
  • p.Pro339= Multiple submitters hereditary neoplastic syndrome
  • p.Pro408= Multiple submitters hereditary neoplastic syndrome
  • p.Pro426= Multiple submitters hereditary neoplastic syndrome
  • p.Pro492= Multiple submitters hereditary neoplastic syndrome
  • p.Pro498= Multiple submitters melanoma, cutaneous malignant, susceptibility to, 8
  • p.Pro505= Multiple submitters Tietz syndrome
  • p.Ser176= Multiple submitters melanoma, cutaneous malignant, susceptibility to, 8
  • p.Ser219= Multiple submitters Tietz syndrome
  • p.Ser258= Multiple submitters Waardenburg syndrome type 2A
  • p.Ser357= Multiple submitters Tietz syndrome
  • p.Ser432= Multiple submitters melanoma, cutaneous malignant, susceptibility to, 8
  • p.Ser472= Multiple submitters hereditary neoplastic syndrome
  • p.Ser502= Multiple submitters Tietz syndrome
  • p.Ser504= Multiple submitters hereditary neoplastic syndrome
  • p.Thr186= Multiple submitters hereditary neoplastic syndrome
  • p.Thr276= Multiple submitters Tietz syndrome
  • p.Thr352= Multiple submitters Tietz syndrome
  • p.Thr443= Multiple submitters hereditary neoplastic syndrome
  • p.Thr454= Multiple submitters hereditary neoplastic syndrome
  • p.Thr456= Multiple submitters hereditary neoplastic syndrome
  • p.Tyr360= Multiple submitters hereditary neoplastic syndrome
  • p.Val358= Multiple submitters hereditary neoplastic syndrome
  • p.Val493= Multiple submitters hereditary neoplastic syndrome
  • c.1031+12C>A Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.1031+12C>T Single submitter Tietz syndrome
  • c.1031+13G>A Single submitter Tietz syndrome
  • c.1031+13G>T Single submitter Tietz syndrome
  • c.1031+17_1031+18del Single submitter Tietz syndrome
  • c.1031+199G>A Single submitter
  • c.1032-14C>A Single submitter Tietz syndrome
  • c.1032-14C>T Single submitter Tietz syndrome
  • c.1032-15C>G Single submitter Tietz syndrome
  • c.1032-16T>C Single submitter Tietz syndrome
  • c.1032-17C>G Single submitter Tietz syndrome
  • c.1032-18C>T Single submitter Tietz syndrome
  • c.1032-4G>C Single submitter Tietz syndrome
  • c.1032-4G>T Single submitter Tietz syndrome
  • c.1032-5C>G Single submitter Tietz syndrome
  • c.1032-7A>G Single submitter Tietz syndrome
  • c.104+24163C>T Single submitter
  • c.104+24230G>T Single submitter
  • c.104+244C>A Single submitter
  • c.104+68C>G Single submitter
  • c.105-12836C>T Single submitter
  • c.105-12G>A Single submitter
  • c.105-19C>T Single submitter
  • c.105-40T>C Single submitter
  • c.1179+10C>T Single submitter Tietz syndrome
  • c.1179+11T>C Single submitter Tietz syndrome
  • c.1179+12G>A Single submitter Tietz syndrome
  • c.1179+17G>T Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.1179+18T>C Single submitter Tietz syndrome
  • c.1179+19G>A Single submitter Tietz syndrome
  • c.1179+7A>G Single submitter Tietz syndrome
  • c.1180-10C>G Single submitter Tietz syndrome
  • c.1180-12C>T Single submitter Tietz syndrome
  • c.1180-14T>C Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.1180-15T>G Single submitter Tietz syndrome
  • c.1180-17C>G Single submitter Tietz syndrome
  • c.1180-18T>C Single submitter Waardenburg syndrome type 2A
  • c.1180-20T>G Single submitter Tietz syndrome
  • c.1180-4A>G Single submitter Tietz syndrome
  • c.1180-5T>C Single submitter Tietz syndrome
  • c.1180-7A>G Single submitter Tietz syndrome
  • c.1180-7A>T Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.1180-8T>A Single submitter Tietz syndrome
  • c.1180-8T>C Single submitter Tietz syndrome
  • c.355-10_355-6del Single submitter Tietz syndrome
  • c.355-1048C>T Single submitter Tietz syndrome
  • c.355-1049T>C Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.355-1050C>A Single submitter Tietz syndrome
  • c.355-1050C>T Single submitter Tietz syndrome
  • c.355-1052G>A Single submitter Waardenburg syndrome type 2A
  • c.355-1057A>T Single submitter Tietz syndrome
  • c.355-15C>A Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.355-15C>T Single submitter Tietz syndrome
  • c.355-18C>A Single submitter Tietz syndrome
  • c.355-18C>T Single submitter Tietz syndrome
  • c.355-5T>C Single submitter Tietz syndrome
  • c.355-6G>A Single submitter
  • c.355-7T>C Single submitter Tietz syndrome
  • c.582+10G>A Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.582+11T>C Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.582+11TCTCC[2] Single submitter Tietz syndrome
  • c.582+11TCTCC[4] Single submitter Tietz syndrome
  • c.582+14C>T Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.582+17C>T Single submitter Tietz syndrome
  • c.582+19C>G Single submitter Waardenburg syndrome type 2A
  • c.582+20C>T Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.582+288T>C Single submitter
  • c.582+7C>G Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.582+8A>G Single submitter Tietz syndrome
  • c.582+8A>T Single submitter Tietz syndrome
  • c.582+9T>A Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.582+9T>C Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.583-10G>T Single submitter Tietz syndrome
  • c.583-16G>C Single submitter Tietz syndrome
  • c.583-16G>T Single submitter Tietz syndrome
  • c.583-20T>A Single submitter Tietz syndrome
  • c.583-335A>G Single submitter
  • c.583-4G>A Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.583-4G>T Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.583-7T>C Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.666+119dup Single submitter
  • c.666+14T>C Single submitter Tietz syndrome
  • c.666+17C>G Single submitter
  • c.666+18A>G Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.666+7A>G Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.667-14C>T Single submitter
  • c.667-15C>T Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.667-5T>C Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.667-6C>A Single submitter Waardenburg syndrome type 2A
  • c.667-6C>T Single submitter Tietz syndrome
  • c.762+12del Single submitter Tietz syndrome
  • c.762+13T>C Single submitter Tietz syndrome
  • c.762+13T>G Single submitter Tietz syndrome
  • c.762+17T>C Single submitter Waardenburg syndrome type 2A
  • c.762+232C>T Single submitter
  • c.762+7A>T Single submitter Tietz syndrome
  • c.763-11TC[3] Single submitter Tietz syndrome
  • c.763-15T>C Single submitter Tietz syndrome
  • c.763-16G>A Single submitter Tietz syndrome
  • c.763-16G>C Single submitter Tietz syndrome
  • c.763-18C>A Single submitter Tietz syndrome
  • c.763-18C>T Single submitter Tietz syndrome
  • c.763-19A>C Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.763-4C>G Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.763-50C>A Single submitter
  • c.880+11A>G Single submitter Tietz syndrome
  • c.880+14A>T Single submitter Tietz syndrome
  • c.880+19T>C Single submitter Tietz syndrome
  • c.880+20G>A Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.880+7A>G Single submitter Tietz syndrome
  • c.880+8C>T Single submitter Waardenburg syndrome type 2A
  • c.881-12T>A Single submitter Tietz syndrome
  • c.881-15C>T Single submitter Tietz syndrome
  • c.881-18C>T Single submitter Tietz syndrome
  • c.881-20G>A Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.881-253A>G Single submitter
  • c.881-275G>C Single submitter
  • c.881-7T>C Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.881-8G>A Single submitter Tietz syndrome
  • c.955+10T>A Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.955+11T>C Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.955+18A>G Single submitter Tietz syndrome
  • c.955+40A>T Single submitter
  • c.955+7T>G Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.955+8G>A Single submitter Waardenburg syndrome type 2A
  • c.955+9G>C Single submitter Tietz syndrome
  • c.956-13T>C Single submitter Waardenburg syndrome type 2A
  • c.956-16T>C Single submitter Waardenburg syndrome type 2A
  • c.956-17G>T Single submitter Waardenburg syndrome type 2A
  • c.956-18T>C Single submitter Tietz syndrome
  • c.956-209G>A Single submitter
  • c.956-265T>A Single submitter
  • c.956-4G>C Single submitter Tietz syndrome
  • c.956-5del Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • c.956-6T>G Single submitter Tietz syndrome
  • c.*2159dup Single submitter
  • p.Ala134= Single submitter hereditary neoplastic syndrome
  • p.Ala183= Single submitter Waardenburg syndrome type 2A
  • p.Ala283= Single submitter Tietz syndrome
  • p.Ala303= Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Ala305= Single submitter Tietz syndrome
  • p.Ala384= Single submitter hereditary neoplastic syndrome
  • p.Arg136= Single submitter hereditary neoplastic syndrome
  • p.Arg290= Single submitter Tietz syndrome
  • p.Arg321= Single submitter hereditary neoplastic syndrome
  • p.Arg322= Single submitter hereditary neoplastic syndrome
  • p.Asn162= Single submitter Tietz syndrome
  • p.Asn279= Single submitter hereditary neoplastic syndrome
  • p.Asn317= Single submitter Waardenburg syndrome type 2A
  • p.Asn326= Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Asn349= Single submitter hereditary neoplastic syndrome
  • p.Asn376= Single submitter hereditary neoplastic syndrome
  • p.Asn430= Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Asn468Ser Single submitter hereditary neoplastic syndrome
  • p.Asn8= Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Asp166= Single submitter hereditary neoplastic syndrome
  • p.Asp225= Single submitter Tietz syndrome
  • p.Asp228= Single submitter Tietz syndrome
  • p.Asp329= Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Asp441= Single submitter Tietz syndrome
  • p.Cys526= Single submitter Tietz syndrome
  • p.Gln132= Single submitter hereditary neoplastic syndrome
  • p.Gln268= Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Gln378= Single submitter hereditary neoplastic syndrome
  • p.Gln437= Single submitter Tietz syndrome
  • p.Glu115= Single submitter
  • p.Glu239= Single submitter hereditary neoplastic syndrome
  • p.Glu291= Single submitter hereditary neoplastic syndrome
  • p.Glu309= Single submitter Tietz syndrome
  • p.Glu320= Single submitter hereditary neoplastic syndrome
  • p.Glu367= Single submitter hereditary neoplastic syndrome
  • p.Glu373= Single submitter Tietz syndrome
  • p.Glu466= Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Gly174= Single submitter hereditary neoplastic syndrome
  • p.Gly195= Single submitter hereditary neoplastic syndrome
  • p.Gly243= Single submitter Tietz syndrome
  • p.Gly274= Single submitter hereditary neoplastic syndrome
  • p.Gly335= Single submitter hereditary neoplastic syndrome
  • p.Gly403= Single submitter hereditary neoplastic syndrome
  • p.Gly453= Single submitter hereditary neoplastic syndrome
  • p.Gly506= Single submitter hereditary neoplastic syndrome
  • p.His167= Single submitter Tietz syndrome
  • p.Ile262= Single submitter hereditary neoplastic syndrome
  • p.Ile277= Single submitter hereditary neoplastic syndrome
  • p.Ile296= Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Ile319= Single submitter Tietz syndrome
  • p.Ile407= Single submitter hereditary neoplastic syndrome
  • p.Leu244= Single submitter hereditary neoplastic syndrome
  • p.Leu261= Single submitter hereditary neoplastic syndrome
  • p.Leu275= Single submitter hereditary neoplastic syndrome
  • p.Leu292= Single submitter melanoma, cutaneous malignant, susceptibility to, 8
  • p.Leu306= Single submitter Waardenburg syndrome type 2A
  • p.Leu334= Single submitter Waardenburg syndrome type 2A
  • p.Leu389= Single submitter hereditary neoplastic syndrome
  • p.Leu406= Single submitter hereditary neoplastic syndrome
  • p.Leu450= Single submitter hereditary neoplastic syndrome
  • p.Leu490= Single submitter hereditary neoplastic syndrome
  • p.Leu5= Single submitter hereditary neoplastic syndrome
  • p.Lys313= Single submitter Tietz syndrome
  • p.Lys332= Single submitter hereditary neoplastic syndrome
  • p.Lys355= Single submitter Tietz syndrome

Uncertain significance 713

Showing the top 300 by review status; the full set is in the sitemap.